Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study

Abstract Background This study aimed to evaluate the efficacy and the safety of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing neutropenia in metastatic colorectal cancer (mCRC) patients that received fluorouracil, leucovorin, oxaliplatin, and irinote...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yusuke Kitagawa, Hiroki Osumi, Eiji Shinozaki, Yumiko Ota, Izuma Nakayama, Takeshi Suzuki, Takeru Wakatsuki, Mariko Ogura, Akira Ooki, Daisuke Takahari, Mitsukuni Suenaga, Keisho Chin, Kensei Yamaguchi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2020-04-01
coleção:	BMC Cancer
Assuntos:	FOLFOXIRI plus bevacizumab Neutropenia Polyethylene glycol conjugated granulocyte colony-stimulating factor
Acesso em linha:	http://link.springer.com/article/10.1186/s12885-020-06864-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!